{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T19:23:47Z","timestamp":1790796227789,"version":"4.1.0"},"reference-count":31,"publisher":"Oxford University Press (OUP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Kidney J"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1093\/ckj\/sfv139","type":"journal-article","created":{"date-parts":[[2015,12,28]],"date-time":"2015-12-28T22:48:41Z","timestamp":1451342921000},"page":"239-244","source":"Crossref","is-referenced-by-count":34,"title":["Minimal change disease onset observed after bevacizumab administration"],"prefix":"10.1093","volume":"9","author":[{"given":"Ramy M.","family":"Hanna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Lopez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shrinath","family":"Barathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur H.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2015,12,28]]},"reference":[{"key":"2016041305273001000_9.2.239.1","doi-asserted-by":"crossref","first-page":"417673","DOI":"10.1155\/2012\/417673","article-title":"Bevacizumab and breast cancer: a meta-analysis of first-line phase III studies and a critical reappraisal of available evidence","volume":"2012","author":"Rossari","year":"2012","journal-title":"J Oncol"},{"key":"2016041305273001000_9.2.239.2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(12)70285-1"},{"key":"2016041305273001000_9.2.239.3","doi-asserted-by":"publisher","DOI":"10.1517\/14712598.2012.745508"},{"key":"2016041305273001000_9.2.239.4","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.3892\/ol.2012.839","article-title":"Carboplatin and bevacizumab for recurrent malignant glioma","volume":"4","author":"Mrugala","year":"2012","journal-title":"Oncol Lett"},{"key":"2016041305273001000_9.2.239.5","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mds590"},{"key":"2016041305273001000_9.2.239.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.nec.2012.02.001"},{"key":"2016041305273001000_9.2.239.7","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-012-2004-x"},{"key":"2016041305273001000_9.2.239.8","doi-asserted-by":"publisher","DOI":"10.1111\/j.1447-0756.2012.01889.x"},{"key":"2016041305273001000_9.2.239.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2012.08.037"},{"key":"2016041305273001000_9.2.239.10","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00180.2012"},{"key":"2016041305273001000_9.2.239.11","doi-asserted-by":"publisher","DOI":"10.1096\/fj.11-202994"},{"key":"2016041305273001000_9.2.239.12","first-page":"4629","article-title":"Utility of hypertension as a surrogate marker for efficacy of antiangiogenic therapy in NSCLC","volume":"32","author":"Evans","year":"2012","journal-title":"Anticancer Res"},{"key":"2016041305273001000_9.2.239.13","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfn657"},{"key":"2016041305273001000_9.2.239.14","doi-asserted-by":"publisher","DOI":"10.1007\/s11912-012-0242-z"},{"key":"2016041305273001000_9.2.239.15","doi-asserted-by":"crossref","first-page":"143426","DOI":"10.1155\/2014\/143426","article-title":"Anti-VEGF cancer therapy in nephrology practice","volume":"2014","author":"Izzedine","year":"2014","journal-title":"Int J Nephrol"},{"key":"2016041305273001000_9.2.239.16","first-page":"421","article-title":"Relapse of minimal change disease nephrotic syndrome after administering intravitreal bevacizumab","volume":"34","author":"Perez-Valdivia","year":"2014","journal-title":"Nefrologia"},{"key":"2016041305273001000_9.2.239.17","doi-asserted-by":"publisher","DOI":"10.1111\/ped.12017"},{"key":"2016041305273001000_9.2.239.18","first-page":"600","article-title":"A case of glomerulopathy associated with the vascular endothelial growth factor inhibitor bevacizumab","volume":"56","author":"Haruhara","year":"2014","journal-title":"Nihon Jinzo Gakkai Shi"},{"key":"2016041305273001000_9.2.239.19","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2007.04.025"},{"key":"2016041305273001000_9.2.239.20","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2004.12.017"},{"key":"2016041305273001000_9.2.239.21","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0707330"},{"key":"2016041305273001000_9.2.239.22","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfl565"},{"key":"2016041305273001000_9.2.239.23","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdq743"},{"key":"2016041305273001000_9.2.239.24","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2004.11.022"},{"key":"2016041305273001000_9.2.239.25","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/17.4.685"},{"key":"2016041305273001000_9.2.239.26","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2004.09.064"},{"key":"2016041305273001000_9.2.239.27","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.05.098"},{"key":"2016041305273001000_9.2.239.28","doi-asserted-by":"publisher","DOI":"10.1080\/1042819031000079140"},{"key":"2016041305273001000_9.2.239.29","unstructured":"Vidal. Herceptin. 2006. http:\/\/www.vidal.fr (12 September 2012, date last accessed)"},{"key":"2016041305273001000_9.2.239.30","doi-asserted-by":"publisher","DOI":"10.1007\/s00408-005-2581-0"},{"key":"2016041305273001000_9.2.239.31","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdp472"}],"container-title":["Clinical Kidney Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ckj\/article-pdf\/9\/2\/239\/7450614\/sfv139.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,2]],"date-time":"2019-09-02T20:46:56Z","timestamp":1567457216000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ckj\/article-lookup\/doi\/10.1093\/ckj\/sfv139"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12,28]]},"references-count":31,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2016,3,15]]},"published-print":{"date-parts":[[2016,4]]}},"alternative-id":["10.1093\/ckj\/sfv139"],"URL":"https:\/\/doi.org\/10.1093\/ckj\/sfv139","relation":{},"ISSN":["2048-8505","2048-8513"],"issn-type":[{"value":"2048-8505","type":"print"},{"value":"2048-8513","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12,28]]}}}